|
Drug Detection Chart
The number of days after intake of a drug that the individual would be expected to excrete detectable levels of drug metabolite in urine is the detection time used in this chart. Variances in time limits due to factors such as dosage, frequency of use, liquid consumption and individual metabolic characteristics are to be expected.
DRUG/FAMILIES |
TRADE NAMES |
APPROXIMATE DETECTION TIME IN DAYS* |
Average |
Possible
|
| Alcohol (Ethanol) |
-- |
0-1 |
-- |
| Amphetamine |
Amphetamine
|
Dexedrine® |
1-2 |
3 |
Methamphetamine ("Crystal Meth")
|
Desoxyn® |
1-2 |
3 |
| Antabuse |
-- |
1-3 |
-- |
| Barbiturates: |
Secobarbital
Pentobarbital
Butalbital
|
Seconal®
Nembutal®
Fiorinal® |
1-2 |
3 |
Phenobarbital
|
Luminal®, Donnatal® |
1-7 |
14-21 |
| Benzodiazepines |
Valium®, Ativan®, Dalmane®, Librium®,
Xanax®, Serax® |
1-9 |
21 |
| Clonazepam |
Klonopin® |
1-3 |
-- |
| Clonidine |
Catapres® |
2-3 |
-- |
| Cocaine |
-- |
2-4 |
7-9 |
| Ethchlorvynol |
Placidyl® |
1-3 |
5 |
| Fentanyl |
-- |
1-3 |
-- |
| Glutethimide |
Doriden® |
1-3 |
-- |
| Hydroxyzine |
Vistaril®, Atarax® |
1-3 |
-- |
| LSD |
-- |
1-3 |
-- |
| Marijuana (Cannabinoids) |
Marinol® |
| 100 ng screen |
-- |
0-22 |
45 |
| 50 ng screen |
-- |
0-30 |
60 |
| 20 ng screen |
-- |
3-46 |
77 |
| MDMA/MDA (Ecstasy) |
-- |
3-5 |
-- |
| Meperidine |
Demerol® |
1-3 |
-- |
| Meprobamate |
Equanil®, Equagesic® |
1-3 |
-- |
| Methadone |
Dolophine® |
1-2 |
3 |
| Methaqualone |
Quaalude® |
1-5 |
14 |
| Naltrexone |
-- |
2-3 |
-- |
| Opiates |
Morphine, Codeine, Dilaudid®, Percodan®,
Tylox® |
1-2 |
3 |
| PCP (Phencyclidine) |
-- |
1-14 |
30 |
| Pentazocine |
Talwin® |
1-3 |
-- |
| Phenmetrazine |
Preludin® |
1-3 |
-- |
| Phenothiazines |
Thorazine®, Phenergan®, Mellaril® |
1-4 |
-- |
| Propoxyphene |
Darvon®, Darvocet® |
1-2 |
-- |
| Prozac |
-- |
2-3 |
-- |
| Psilocybin (mushrooms) |
-- |
1-2 |
-- |
| Quinine |
-- |
1-3 |
5 |
| Ritalin |
-- |
2-3 |
-- |
| Tricyclic Antidepressant |
Elavil®, Sinequan®, Tofranil®, Pamelor® |
1-4 |
9 |
|
